Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Ondansetron for the Treatment of Methamphetamine Dependence - 1

ClinicalTrials.gov ID: NCT00040053

Public ClinicalTrials.gov record NCT00040053. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Double-Blind, Placebo-Controlled, Dose Response Trial of Ondansetron for the Treatment of Methamphetamine Dependence.

Study identification

NCT ID
NCT00040053
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute on Drug Abuse (NIDA)
NIH
Enrollment
154 participants

Conditions and interventions

Interventions

  • Ondansetron Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2002
Primary completion
Not listed
Completion
Jan 31, 2004
Last update posted
Jan 11, 2017

2002 – 2004

United States locations

U.S. sites
6
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
South Bay Treatment Center Chula Vista California 91911
Matrix Institute on Addictions Costa Mesa California 92627
John A. Burns School of Medicine Honolulu Hawaii 96813
Powell Chemical Dependency Center Des Moines Iowa 50316
University of Missouri - Kansas City Kansas City Missouri 64108
University of Texas Health Science Center Houston Texas 77225

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00040053, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 11, 2017 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00040053 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →